Cr étaient disponibles pour 56% des patients (n=34) La moyenne des valeurs du ratio Cho/NAA dans le groupe P, pp.8358-91 ,
Cr dans le groupe P était de 1,11 ± 0,33 (min : 0,68- max : 1,83) versus 1,13 ± 0, pp.3178-76 ,
A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis, 1926. ,
Tumors of the central nervous system. Atlas of tumor pathology (fasc 35) Armed Forces Institute of Pathology, 1952. ,
Types histologiques du système nerveux central, Genève: OMS, 1979. ,
Histological typing of tumours of the central nervous system.World Health Organization international histological classification of tumours, Heildelberg, 1993. ,
World Health Organization Classification of Tumours ,
The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, pp.11-97, 2007. ,
Epidemiology and etiology of gliomas, Acta Neuropathologica, vol.43, issue.1, 2005. ,
DOI : 10.1007/s00401-005-0991-y
Epidemiology of Gliomas, Cancer Treat Res, vol.163, pp.1-14, 2015. ,
DOI : 10.1007/978-3-319-12048-5_1
A population-based study of the incidence and survival rates in patients with astrocytic pilocytoma, J Neurosurg, vol.98, issue.6, pp.1170-1174, 2003. ,
The epidemiology of glioma in adults: a "state of the science" review, Neuro-Oncology, vol.17, issue.4 ,
DOI : 10.1093/neuonc/nou358
Diagnosis and Treatment of High-Grade Astrocytoma, Neurologic Clinics, vol.25, issue.4, pp.1111-1150, 2007. ,
DOI : 10.1016/j.ncl.2007.07.004
II: a new grading system based on morphological and imaging criteria, J Neurooncol, vol.34, pp.61-78, 1997. ,
Input of molecular analysis in medical management of primary brain tumor patients, Rev Neurol, vol.171, pp.6-7457, 2015. ,
Epidemiology of brain metastases. Cancer Radiother, 2015. ,
Les diff??rents visages des m??tastases du syst??me nerveux central, Journal de Radiologie Diagnostique et Interventionnelle, vol.95, issue.10, pp.908-930, 2014. ,
DOI : 10.1016/j.jradio.2014.05.007
Cerebral metastases. A study of a surgical series of 81 casesClinical symptoms and symptomatic management of brain metastases, Neurochirurgie Bull Cancer, vol.38, issue.984, pp.89-97371, 1992. ,
Extirpation of glioblastomas : MR and CT follow-up of residual tumor and regrowth patterns, AJNR Am J Neuroradiol, vol.14, issue.1, pp.77-87, 1993. ,
Gliadel?? Wafers in the Treatment of Malignant Glioma: A Systematic Review, Current Oncology, vol.14, issue.5, pp.189-94, 2007. ,
DOI : 10.3747/co.2007.147
Chemotherapy wafers for high grade glioma.Cochrane Database Syst Rev, 2011. ,
Defining pseudoprogression in glioblastoma multiforme, Eur J Neurol, vol.20, issue.10, pp.1335-1376, 2013. ,
Pseudoprogression in high-grade glioma, Acta Neurologica Scandinavica, vol.94, issue.196, pp.31-38, 2013. ,
DOI : 10.1111/ane.12047
Pseudoprogression: Relevance With Respect to Treatment of High-Grade Gliomas, Current Treatment Options in Oncology, vol.22, issue.6, pp.240-52, 2011. ,
DOI : 10.1007/s11864-011-0157-1
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas, The Lancet Oncology, vol.9, issue.5, pp.453-61, 2008. ,
DOI : 10.1016/S1470-2045(08)70125-6
Pseudoprogression and MGMT status in glioblastoma patients : implications in clinical practice, Anticancer Res, vol.29, issue.7, pp.2607-2617, 2009. ,
Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients, Journal of Clinical Oncology, vol.26, issue.13, pp.2192-7387, 2008. ,
DOI : 10.1200/JCO.2007.14.8163
Use of bevacizumab in recurrent glioblastoma, CNS Oncology, vol.4, issue.3 ,
DOI : 10.2217/cns.15.8
Bevazicumab for recurrent glioblastoma multiforme : a meta-analysis, J Natl Compr Canc Netw. 2011, vol.9, issue.4, pp.403-410 ,
Management of brain metastases: the indispensable role of surgery, Journal of Neuro-Oncology, vol.51, issue.3, pp.275-82, 2009. ,
DOI : 10.1007/s11060-009-9839-y
Current management of brain metastases, Rev Neurol, vol.164, pp.6-7560, 2008. ,
Brain metastases: an overview, CNS Oncology, vol.4, issue.1, pp.37-46, 2015. ,
DOI : 10.2217/cns.14.51
Radioth??rapie en conditions st??r??otaxiques des m??tastases c??r??brales, Cancer/Radioth??rapie, vol.19, issue.1, pp.25-34, 2015. ,
DOI : 10.1016/j.canrad.2014.12.002
Gamma Knife Radiosurgery for Ten or More Brain Metastases, Journal of Korean Neurosurgical Society, vol.44, issue.6, pp.358-363, 2008. ,
DOI : 10.3340/jkns.2008.44.6.358
Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases, J Neurosurg, vol.117, pp.237-245, 2012. ,
Surgery versus radiosurgery in the treatment of brain metastasis, Journal of Neurosurgery, vol.84, issue.5, pp.748-54, 1996. ,
DOI : 10.3171/jns.1996.84.5.0748
The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence, International Journal of Molecular Sciences, vol.15, issue.7, pp.11832-46377, 1986. ,
DOI : 10.3390/ijms150711832
Cerebral ?radiation necrosis?: Vascular and glial features, Acta Neuropathologica, vol.12, issue.4, pp.243-252, 1976. ,
DOI : 10.1007/BF00699643
Progressive enlargement of a mass lesion in late cerebral radionecrosis, Journal of Clinical Neuroscience, vol.18, issue.6, pp.853-858, 2011. ,
DOI : 10.1016/j.jocn.2010.08.041
Imaging of irradiated brain tumours: value of magnetic resonance imaging, J. Neuroradiol, vol.16, pp.81-132, 1989. ,
The fibrinolytic enzymes in the biology of brain tumors ,
Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma, Journal of Neurosurgery, vol.113, issue.2, pp.293-300, 2010. ,
DOI : 10.3171/2010.1.JNS091039
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time, International Journal of Radiation Oncology*Biology*Physics, vol.53, issue.1, pp.75-85, 2002. ,
DOI : 10.1016/S0360-3016(02)02711-6
Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.2, pp.499-508, 2006. ,
DOI : 10.1016/j.ijrobp.2005.12.002
Irradiated Volume as a Predictor of Brain Radionecrosis After Linear Accelerator Stereotactic Radiosurgery, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.4, pp.419-443, 2006. ,
DOI : 10.1016/j.ijrobp.2009.06.006
12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors, International Journal of Radiation Oncology*Biology*Physics, vol.64, issue.2, pp.419-443, 2006. ,
DOI : 10.1016/j.ijrobp.2005.07.980
Treatment of Cerebral Radionecrosis by Hyperbaric Oxygen Therapy, Stereotactic and Functional Neurosurgery, vol.70, issue.1, pp.229-265, 1998. ,
DOI : 10.1159/000056426
Challenges with the diagnosis and treatment of cerebral radiation necrosis, Int J Radiat Oncol Biol Phys, vol.87, issue.3, pp.449-57, 2013. ,
An analysis of radiation necrosis of the central nervous system treated with bevacizumab, J Neurooncol, vol.117, issue.2, pp.321-328, 2014. ,
Le b??vacizumab dans le traitement des radion??croses c??r??brales, Revue Neurologique, vol.167, issue.4, pp.331-337, 2011. ,
DOI : 10.1016/j.neurol.2010.10.012
The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles, Journal of Neuro-Oncology, vol.16, issue.3, pp.423-454, 2011. ,
DOI : 10.1007/s11060-011-0610-9
Multimodal magnetic resonance imaging of brain tumors, Rev Neurol, vol.167, issue.10, pp.70-74, 2011. ,
Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis, Int J Radiat Oncol Biol Phys AJNR Am J Neuroradiol, vol.54, issue.268, pp.842-54, 2002. ,
MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas, Journal of Medical Imaging and Radiation Oncology, vol.77, issue.3, pp.349-55, 2013. ,
DOI : 10.1111/j.1754-9485.2012.02472.x
Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation 159 ,
DOI : 10.1016/j.mri.2011.04.004
A Comprehensive Review of MR Imaging Changes following Radiosurgery to 500 Brain Metastases, American Journal of Neuroradiology, vol.32, issue.10, pp.1885-92, 2011. ,
DOI : 10.3174/ajnr.A2668
CAN STANDARD MAGNETIC RESONANCE IMAGING RELIABLY DISTINGUISH RECURRENT TUMOR FROM RADIATION NECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES? A RADIOGRAPHIC-PATHOLOGICAL STUDY, Neurosurgery, vol.63, issue.5, pp.898-904, 2008. ,
DOI : 10.1227/01.NEU.0000333263.31870.31
T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery Extent of perilesional oedema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases, Neurosurgery Neuro Oncol, vol.66, issue.1512, pp.48691-711732, 2010. ,
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology, American Journal of Roentgenology, vol.188, issue.6, pp.1622-1657, 2007. ,
DOI : 10.2214/AJR.06.1403
Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI. Diag Interv Imaging, pp.958-1000, 2014. ,
Diffusion-weighted imaging of radiation-induced brain injury for differentiation rom tumor recurrence, Am J Neuroradiol, vol.26, issue.6, pp.1455-60, 2005. ,
Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury, AJNR Am J Neuroradiol, vol.25, issue.2, pp.201-210, 2004. ,
Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy, Folia Neuropathol, vol.48, issue.2, pp.81-92, 2010. ,
Diffusion-Weighted Magnetic Resonance Imaging in Radiation-Induced Cerebral Necrosis, Journal of Computer Assisted Tomography, vol.27, issue.5, pp.674-80, 2003. ,
DOI : 10.1097/00004728-200309000-00003
Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging, pp.1187-204, 2013. ,
Perfusion Imaging in Neuro-Oncology, Magnetic Resonance Imaging Clinics of North America, vol.24, issue.4, pp.497-511, 2015. ,
DOI : 10.1016/j.mric.2016.07.004
Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroiamging Clin N Am, pp.527-57, 2009. ,
Perfusion imaging in brain disease. Diagn Interv Imaging, pp.1241-57, 2013. ,
IRM de perfusion des tumeurs c??r??brales, Journal de Radiologie, vol.87, issue.6, pp.807-828, 2006. ,
DOI : 10.1016/S0221-0363(06)74089-6
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptbility-weighted contrast-enhanced perfusion MR imaging measurements, AJNR Am J Neuroradiol, vol.30, issue.3, pp.552-560, 2009. ,
Innovative prevention strategies for radiation necrosis of the central nervous system Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproductibility study, Anticancer Res Radiology, vol.22, issue.224, pp.1017-1023797, 2002. ,
Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging, American Journal of Neuroradiology, vol.30, issue.2, pp.367-721078, 2007. ,
DOI : 10.3174/ajnr.A1362
Dynamic susceptibility contrast MR imaging: Correlation of signal intensity changes with cerebral blood volume measurements, Journal of Magnetic Resonance Imaging, vol.14, issue.2, pp.114-133, 2000. ,
DOI : 10.1002/(SICI)1522-2586(200002)11:2<114::AID-JMRI6>3.0.CO;2-S
Idy-Peretti I. MR diffusion and perfusion imaging in clinical practice, J Neuroradiol, vol.27, issue.1, pp.39-51, 2000. ,
Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors, Radiology, vol.249, issue.2, pp.601-614, 2008. ,
DOI : 10.1148/radiol.2492071659
Evaluation of treatment-induced cerebral white matter injury by using diffusion tensor MR imaging : initial experience DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma, AJNR Am J Neuroradiol Clin Radiol, vol.26, issue.696, pp.2200-2206, 2005. ,
Proton magnetic resonance spectroscopy (1H-MRS) for the diagnosis of brain tumors and the evaluation of treatment ,
MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injurySerial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery, Acad Radiol. Am J Neuroradiol, vol.18, issue.22, pp.613-637, 2001. ,
Localized proton spectroscopy of inoperable brain gliomas Response to radiation therapyDeveloping a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions, J Neurooncol AJR Am J Roentgenol, vol.17, issue.1922, pp.27-35, 1993. ,
Detection of an intense resonance at ,
Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors, NMR in Biomedicine, vol.16, issue.1 ,
DOI : 10.1002/nbm.793
Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy, AJNR Am J Neuroradiol, vol.22, pp.1316-1340, 2001. ,
MR of toxic effects of accelerated fractionation radiation therapy and carboplatin chemotherapy for malignant gliomas, Am J Neuroradiol, vol.16, pp.715-726, 1995. ,
Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis, Journal of Clinical Neuroscience, vol.22, issue.2, pp.229-266, 2015. ,
DOI : 10.1016/j.jocn.2014.06.102
Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies, Journal of Neuro-Oncology, vol.75, issue.2, pp.177-83, 2006. ,
DOI : 10.1007/s11060-005-9018-8
Positron emission tomography in clinical oncology, Presse Med, pp.276-83, 2003. ,
Positron emission tomography in internal medicine, 2007. ,
On the Origin of Cancer Cells, Science, vol.123, issue.3191, pp.75-83, 1956. ,
DOI : 10.1126/science.123.3191.309
Quelle place en oncologie thoracique pour la tomographie par ??mission de positons au 18FDG (TEP-FDG) en 2010???, Revue de Pneumologie Clinique, vol.66, issue.4, pp.221-259, 2010. ,
DOI : 10.1016/j.pneumo.2010.07.010
Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis, Journal of Neuro-Oncology, vol.35, issue.8, pp.137-183, 2011. ,
DOI : 10.1007/s11060-010-0365-8
PET in differentiation of recurrent brain tumor from radiation injury, J Nucl Med, vol.41, issue.11, pp.1861-1868, 2000. ,
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery, International Journal of Cancer, vol.36, issue.3, pp.191-198, 2001. ,
DOI : 10.1002/ijc.1016
La TEP dans les tumeurs malignes c??r??brales, La Presse M??dicale, vol.35, issue.9, pp.1347-53, 2006. ,
DOI : 10.1016/S0755-4982(06)74818-7
Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis?, Journal of Clinical Neuroscience, vol.19, issue.5, pp.633-640 ,
DOI : 10.1016/j.jocn.2011.10.003
Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis.Cancer Radiother, pp.142-148, 2014. ,
Value of 11C-methionine PET in imaging brain tumours and metastases, European Journal of Nuclear Medicine and Molecular Imaging, vol.40, issue.Suppl 3, pp.615-650, 2013. ,
DOI : 10.1007/s00259-012-2295-5
11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral Gliomas, Molecular Imaging and Biology, vol.144, issue.1, pp.1-18 ,
DOI : 10.1007/s11307-007-0115-2
FET-PET imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients-A Review. Front Oncol, p.104, 2013. ,
O -(2-[ 18 F]Fluoroethyl)- l -tyrosine and l -[methyl- 11 C]methionine uptake in brain tumours: initial results of a comparative study, European Journal of Nuclear Medicine and Molecular Imaging, vol.27, issue.5, pp.542-551, 2000. ,
DOI : 10.1007/s002590050541
Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.11, pp.1464-70, 2004. ,
DOI : 10.1007/s00259-004-1590-1
Fluroethyltyrosine 18 F PET in the detection of brain tumours. Bull Cancer, pp.495-506, 2010. ,
The use of dynamic O-(2-18-F- fluoroethyl)-I-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma, Neuro Oncol, 201524. ,
18 F-DOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy, J Nucl Med, vol.47, issue.6, pp.904-915, 2006. ,
Brain tumour imaging with PET : a comparison between (18F] fluorodopa and [11C] methionine, Eur J Nucl Med Mol Imaging ,
F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases, Expert Review of Medical Devices, vol.11, issue.4, pp.327-336 ,
DOI : 10.1586/17434440.2014.925396
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery, European Journal of Nuclear Medicine and Molecular Imaging, vol.66, issue.Suppl, pp.103-114 ,
DOI : 10.1007/s00259-014-2886-4
Comparative diagnostic accuracy of contrast-enhanced MRI and 18F-FDOPA PET-CT in recurrent glioma, European Radiology, vol.31, issue.9, pp.2628-2663, 2013. ,
DOI : 10.1007/s00330-013-2838-6
Which Combination of MR Imaging Modalities Is Best for Predicting Recurrent Glioblastoma? Study of Diagnostic Accuracy and Reproducibility, Radiology, vol.273, issue.3, pp.831-874, 2014. ,
DOI : 10.1148/radiol.14132868
Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence, Journal of Neuroimaging, vol.33, issue.1, 2015. ,
DOI : 10.1111/jon.12247
Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain, The Neuroradiology Journal, vol.162, issue.6, pp.112-121 ,
DOI : 10.1007/978-1-4419-0318-1
Value of relative cerebral blood volume measurement using perfusion MRI in glioma management ,
Distinguishing Recurrent High-grade Gliomas from Radiation Injury, Academic Radiology, vol.18, issue.5, pp.575-83, 2011. ,
DOI : 10.1016/j.acra.2011.01.018
Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosis, Journal of the Neurological Sciences, vol.351, issue.1-2, pp.65-71, 2015. ,
DOI : 10.1016/j.jns.2015.02.038
Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis, European Journal of Radiology, vol.83, issue.12, pp.2181-2190, 2014. ,
DOI : 10.1016/j.ejrad.2014.09.018
Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab, Journal of Neuro-Oncology, vol.88, issue.2, 2011. ,
DOI : 10.1007/s11060-010-0397-0
Current status of 18F-DOPA PET imaging in the detection of brain tumor recurrence, Hell J Nucl Med, 2015. ,
The role of LAT1 in 18F-DOPA uptake in malignant gliomas, Journal of Neuro-Oncology, vol.101, issue.1, pp.11-19, 2013. ,
DOI : 10.1007/s11060-012-0986-1
Transport of 3-Fluoro-L-??-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET, Journal of Nuclear Medicine, vol.53, issue.8, pp.1253-61, 2012. ,
DOI : 10.2967/jnumed.112.103069
Etude de l'expression de LAT1 dans les métastases cérébrales.Human health and Pathology, 2013. ,
18F-DOPA PET for the diagnosis of brain tumor recurrence: Correlation to LAT 1 expression, J Nuclear Med, vol.55, p.1889, 2014. ,
MRI perfusion in determining pseudoprogression in patients with gliobastoma ,